查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813299

生医材料市场预测（至 2032 年）：按类型、应用和地区分類的全球分析

Biomaterials Market Forecasts to 2032 - Global Analysis By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Other Types), Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生医材料市场预计在 2025 年达到 494 亿美元，到 2032 年将达到 920.6 亿美元，预测期内的复合年增长率为 9.3%。

生医材料是天然或合成材料，旨在与生物系统相互作用，用于医疗或治疗目的。它们包括金属、陶瓷、聚合物和复合材料，经过精心设计，用于修復、替换或增强组织和器官功能。生医材料用于植入、矫正器具、药物传递系统和组织工程等应用，必须具备生物相容性、耐久性和功能性，且不会引发不良免疫反应。其设计通常融合了生物学、化学、材料科学和工程学，以满足特定的临床需求。生医材料将技术与生物学紧密结合，在推动现代医疗保健、再生医学和生物医学创新方面发挥关键作用。

慢性病和心血管疾病盛行率上升

全球预期寿命的延长以及与生活方式相关的健康问题持续推动对先进生医材料的需求。再生疗法和外科手术极大地受益于这些材料的兼容性和性能。微创手术进一步推动了其在临床环境中的应用。不断增长的医疗保健需求强化了生医材料的战略重要性。这些不断发展的医疗需求决定了长期的市场成长。

严格的法规和临床核准流程

医疗级材料必须符合严格的安全和性能标准。核准週期长且因司法管辖区而异，增加了合规成本。这些挑战阻碍了创新并延迟了商业化。中小企业可能难以满足这些要求。监管碎片化持续限制市场的快速扩张。

植入式医疗设备的普及率不断提高

与人体组织的整合需要具有高生物相容性和结构可靠性的生医材料。其应用范围广泛，包括整形外科植入、心血管支架、牙科修復体、神经假体介面。材料工程的持续进步正在提升材料的耐用性、功能性和患者疗效。全球医疗保健系统对微创、持久的医疗解决方案偏好日益增长。应用趋势正在加速生医材料领域的创新週期。

研发生产成本高

开发安全有效的材料需要在研究、测试和合规方面投入大量资金。生产过程通常专业化且资本密集。规模较小的公司可能难以与现有企业竞争。这些成本压力减缓了产品和市场的开发。经济壁垒仍然是成长的持续威胁。

COVID-19的影响：

新冠疫情对生医材料市场产生了多方面的影响。最初，供应链中断、製造业停滞以及选择性医疗程序的减少阻碍了需求。医院优先考虑紧急护理，并推迟了包括植入和义肢在内的手术。然而，疫情加速了生医材料在医疗设备、诊断设备和个人防护设备的应用。医疗基础设施和研究投资的增加进一步支持了市场復苏。疫情过后，人们对先进医疗解决方案和再生医学的关注度不断提高，刺激了对生医材料的需求。

预计聚合物生医材料领域将成为预测期内最大的领域

预计聚合物生医材料领域将在预测期内占据最大的市场份额，这得益于其适应性强、临床效用范围广泛。这些材料广泛应用于心血管、整形外科和伤口护理领域。其柔韧性、生物相容性和易于自订的特性使其成为满足各种医疗需求的理想选择。可生物降解和药物释放聚合物的创新正在拓展其应用范围。它们还支持微创治疗。预计该领域将继续在产量和创新方面保持领先地位。

预计预测期内眼科领域将以最高的复合年增长率成长。

预计眼科领域将在预测期内实现最高成长率，刺激精准眼部护理解决方案的需求。生医材料用于人工水晶体、角膜支架和眼部给药系统。人口老化和视障患者数量的增加推动了生物材料的应用。透明且生物相容性的材料正在改善手术效果。微创眼科手术在全球越来越受欢迎。预计未来几年该领域将迅速扩张。

比最大的地区

在预测期内，由于创新医疗技术的高采用率和强大的研发活动，预计北美将占据最大的市场份额。生医材料在该地区广泛应用于整形外科、心血管设备、创伤治疗和整容手术。大学、研究机构和生物技术公司之间的策略联盟正在推动技术创新和产品开发。成熟的行业参与者、有利的监管政策以及对微创治疗日益增长的偏好共同推动着市场扩张。个人化医疗和再生医学意识的不断提高也增强了市场前景。

复合年增长率最高的地区：

在预测期内，由于快速的都市化、医疗基础设施的扩张以及对先进医疗技术的投资不断增加，预计亚太地区将呈现最高的复合年增长率。慢性病盛行率的上升以及对整形外科、心血管和牙科植入需求的不断增长，进一步推动了市场成长。中国、印度和日本等国家因其庞大的患者群体和更便利的医疗服务而发挥关键作用。此外，政府推动生医材料研究和本地生产的倡议正在刺激技术创新，使该地区成为未来市场扩张和发展的热点。

免费客製化服务

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生医材料市场类型

  • 金属生医材料
    • 不銹钢
    • 钛及钛合金
    • 钴铬合金
  • 聚合物生医材料
    • 聚甲基丙烯酸甲酯（PMMA）
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚氯乙烯（PVC）
    • 硅酮
  • 陶瓷生医材料
    • 氧化铝
    • 氧化锆
    • 磷酸钙
  • 天然生医材料
    • 胶原蛋白
    • 明胶
    • 几丁聚醣
    • 藻酸盐
    • 丝绸
    • 玻尿酸
  • 其他类型

6. 全球生医材料市场（按应用）

  • 心血管系统
    • 支架和移植物
    • 心臟瓣膜
    • 心律调节器和植入式装置
  • 整形外科
    • 关节重建
    • 接骨板和螺丝
    • 脊椎移植
  • 眼科
    • 隐形眼镜
    • 人工水晶体
    • 角膜植入
  • 牙科
    • 人工植牙
    • 牙冠和牙桥
    • 假牙
  • 伤口癒合
    • 手术缝合线
    • 组织密封胶和黏合剂
    • 敷料
  • 神经病学
    • 神经植入
    • 分流
    • 电极
  • 其他应用

7. 全球生医材料市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第八章：主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第九章：企业概况

  • BASF SE
  • Evonik Industries AG
  • Corbion NV
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Victrex plc
  • Zimmer Biomet
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • DSM-Firmenich
  • Noble Biomaterials Inc.
  • CoorsTek Inc.
  • CeramTec GmbH
Product Code: SMRC30760

According to Stratistics MRC, the Global Biomaterials Market is accounted for $49.40 billion in 2025 and is expected to reach $92.06 billion by 2032 growing at a CAGR of 9.3% during the forecast period. Biomaterials are natural or synthetic substances designed to interact with biological systems for medical or therapeutic purposes. They can be metals, ceramics, polymers, or composites, carefully engineered to restore, replace, or enhance the function of tissues and organs. Used in applications such as implants, prosthetics, drug delivery systems, and tissue engineering, biomaterials must exhibit biocompatibility, durability, and functionality without causing adverse immune responses. Their design often integrates biology, chemistry, materials science, and engineering to meet specific clinical needs. By bridging technology and biology, biomaterials play a crucial role in advancing modern healthcare, regenerative medicine, and biomedical innovation.

Market Dynamics:

Driver:

Rising prevalence of chronic and cardiovascular diseases

Rising global life expectancy and lifestyle-induced health issues continue to elevate demand for advanced biomaterials. Regenerative therapies and surgical applications benefit significantly from these materials' compatibility and performance. Minimally invasive procedures further drive utilization across clinical settings. Expanding healthcare needs are reinforcing the strategic importance of biomaterials. Long-term market growth is being shaped by these evolving medical requirements.

Restraint:

Stringent regulatory and clinical approval processes

Medical-grade materials must meet rigorous safety and performance standards. Approval cycles are lengthy and vary across jurisdictions, increasing compliance costs. These challenges slow down innovation and delay commercialization. Smaller firms may find it difficult to navigate these requirements. Regulatory fragmentation continues to restrict rapid market expansion.

Opportunity:

Growing adoption of implantable medical devices

Integration with human tissue demands biomaterials that exhibit high biocompatibility and structural reliability. Applications span orthopedic implants, cardiovascular stents, dental restorations, and neuroprosthetic interfaces. Continuous advancements in material engineering are enhancing durability, functionality, and patient outcomes. Preference for minimally invasive and long-lasting medical solutions is rising across global healthcare systems. Adoption trends are accelerating innovation cycles within the biomaterials sector.

Threat:

High R&D and production costs

Developing safe and effective materials requires substantial investment in research, testing, and regulatory compliance. Production processes are often specialized and capital-intensive. Smaller players may struggle to compete with established firms. These cost pressures slow product development and market penetration. Economic barriers remain a persistent threat to growth.

Covid-19 Impact:

The Covid-19 pandemic had a mixed impact on the biomaterials market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced elective medical procedures hindered demand. Hospitals prioritized emergency care, delaying surgeries involving implants and prosthetics. However, the pandemic also accelerated the use of biomaterials in medical devices, diagnostics, and personal protective equipment. Increased investments in healthcare infrastructure and research further supported market recovery. Post-pandemic, rising focus on advanced healthcare solutions and regenerative medicine boosted demand for biomaterials.

The polymeric biomaterials segment is expected to be the largest during the forecast period

The polymeric biomaterials segment is expected to account for the largest market share during the forecast period due to their adaptability and broad clinical utility. These materials are widely used in cardiovascular, orthopedic, and wound care applications. Their flexibility, biocompatibility, and ease of customization make them ideal for diverse medical needs. Innovations in biodegradable and drug-releasing polymers are expanding their scope. They also support minimally invasive treatment approaches. This segment will continue to lead in both volume and innovation.

The ophthalmology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ophthalmology segment is predicted to witness the highest growth rate increasing demand for precision eye care solutions. Biomaterials are being used in intraocular lenses, corneal scaffolds, and ocular drug delivery systems. Aging populations and rising cases of vision impairment are fuelling adoption. Transparent and biocompatible materials are improving surgical outcomes. Minimally invasive ophthalmic procedures are gaining traction globally. This segment is poised for rapid expansion in the coming years.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share by high adoption of innovative medical technologies, and strong research and development activities. The region shows widespread use of biomaterials in orthopedics, cardiovascular devices, wound healing, and cosmetic surgery. Strategic collaborations between universities, research institutions, and biotech firms foster innovation and product development. Established industry players, favorable regulatory policies, and the rising preference for minimally invasive treatments collectively fuel market expansion. Growing awareness about personalized healthcare and regenerative medicine also strengthens the market landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rapid urbanization, an expanding healthcare infrastructure, and growing investments in advanced medical technologies. Increasing prevalence of chronic diseases and rising demand for orthopedic, cardiovascular, and dental implants further support market growth. Countries such as China, India, and Japan play a significant role due to large patient populations and improving healthcare access. Additionally, government initiatives promoting research and local production of biomaterials encourage innovation, making the region a hotspot for future market expansion and development.

Key players in the market

Some of the key players in Biomaterials Market include BASF SE, Evonik Industries AG, Corbion N.V., Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Victrex plc, Zimmer Biomet, Johnson & Johnson, Medtronic plc, Stryker Corporation, DSM-Firmenich, Noble Biomaterials Inc., CoorsTek Inc. and CeramTec GmbH.

Key Developments:

In July 2025, BASF signed a global framework agreement with CATL to supply advanced cathode active materials for lithium-ion batteries. While focused on energy storage, the partnership leverages BASF's biomaterials expertise in sustainable sourcing and circular chemistry to support CATL's green transformation goals.

In January 2025, Evonik formed a joint venture with Fuhua Tongda Chemical Co., Ltd. in Sichuan, China, to produce specialty hydrogen peroxide for medical and semiconductor applications. The venture builds on a prior licensing agreement and supports Evonik's biomaterials strategy by securing sustainable raw materials for high-purity processing.

Types Covered:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Other Types

Applications Covered:

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Wound Healing
  • Wound Healing
  • Neurology
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomaterials Market, By Type

  • 5.1 Introduction
  • 5.2 Metallic Biomaterials
    • 5.2.1 Stainless Steel
    • 5.2.2 Titanium & Titanium Alloys
    • 5.2.3 Cobalt-Chromium Alloys
  • 5.3 Polymeric Biomaterials
    • 5.3.1 Polymethyl Methacrylate (PMMA)
    • 5.3.2 Polyethylene (PE)
    • 5.3.3 Polypropylene (PP)
    • 5.3.4 Polyvinyl Chloride (PVC)
    • 5.3.5 Silicone
  • 5.4 Ceramic Biomaterials
    • 5.4.1 Alumina
    • 5.4.2 Zirconia
    • 5.4.3 Calcium Phosphates
  • 5.5 Natural Biomaterials
    • 5.5.1 Collagen
    • 5.5.2 Gelatin
    • 5.5.3 Chitosan
    • 5.5.4 Alginate
    • 5.5.5 Silk
    • 5.5.6 Hyaluronic Acid
  • 5.6 Other Types

6 Global Biomaterials Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular
    • 6.2.1 Stents & Grafts
    • 6.2.2 Heart Valves
    • 6.2.3 Pacemakers & Implantable Devices
  • 6.3 Orthopedic
    • 6.3.1 Joint Replacement
    • 6.3.2 Bone Plates & Screws
    • 6.3.3 Spinal Implants
  • 6.4 Ophthalmology
    • 6.4.1 Contact Lenses
    • 6.4.2 Intraocular Lenses
    • 6.4.3 Corneal Implants
  • 6.5 Dental
    • 6.5.1 Dental Implants
    • 6.5.2 Crowns & Bridges
    • 6.5.3 Dentures
  • 6.6 Wound Healing
    • 6.6.1 Surgical Sutures
    • 6.6.2 Tissue Sealants & Adhesives
    • 6.6.3 Dressings
  • 6.7 Neurology
    • 6.7.1 Neural Implants
    • 6.7.2 Shunts
    • 6.7.3 Electrodes
  • 6.8 Other Applications

7 Global Biomaterials Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 BASF SE
  • 9.2 Evonik Industries AG
  • 9.3 Corbion N.V.
  • 9.4 Covestro AG
  • 9.5 Celanese Corporation
  • 9.6 Carpenter Technology Corporation
  • 9.7 Victrex plc
  • 9.8 Zimmer Biomet
  • 9.9 Johnson & Johnson
  • 9.10 Medtronic plc
  • 9.11 Stryker Corporation
  • 9.12 DSM-Firmenich
  • 9.13 Noble Biomaterials Inc.
  • 9.14 CoorsTek Inc.
  • 9.15 CeramTec GmbH

List of Tables

  • Table 1 Global Biomaterials Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biomaterials Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Biomaterials Market Outlook, By Metallic Biomaterials (2024-2032) ($MN)
  • Table 4 Global Biomaterials Market Outlook, By Stainless Steel (2024-2032) ($MN)
  • Table 5 Global Biomaterials Market Outlook, By Titanium & Titanium Alloys (2024-2032) ($MN)
  • Table 6 Global Biomaterials Market Outlook, By Cobalt-Chromium Alloys (2024-2032) ($MN)
  • Table 7 Global Biomaterials Market Outlook, By Polymeric Biomaterials (2024-2032) ($MN)
  • Table 8 Global Biomaterials Market Outlook, By Polymethyl Methacrylate (PMMA) (2024-2032) ($MN)
  • Table 9 Global Biomaterials Market Outlook, By Polyethylene (PE) (2024-2032) ($MN)
  • Table 10 Global Biomaterials Market Outlook, By Polypropylene (PP) (2024-2032) ($MN)
  • Table 11 Global Biomaterials Market Outlook, By Polyvinyl Chloride (PVC) (2024-2032) ($MN)
  • Table 12 Global Biomaterials Market Outlook, By Silicone (2024-2032) ($MN)
  • Table 13 Global Biomaterials Market Outlook, By Ceramic Biomaterials (2024-2032) ($MN)
  • Table 14 Global Biomaterials Market Outlook, By Alumina (2024-2032) ($MN)
  • Table 15 Global Biomaterials Market Outlook, By Zirconia (2024-2032) ($MN)
  • Table 16 Global Biomaterials Market Outlook, By Calcium Phosphates (2024-2032) ($MN)
  • Table 17 Global Biomaterials Market Outlook, By Natural Biomaterials (2024-2032) ($MN)
  • Table 18 Global Biomaterials Market Outlook, By Collagen (2024-2032) ($MN)
  • Table 19 Global Biomaterials Market Outlook, By Gelatin (2024-2032) ($MN)
  • Table 20 Global Biomaterials Market Outlook, By Chitosan (2024-2032) ($MN)
  • Table 21 Global Biomaterials Market Outlook, By Alginate (2024-2032) ($MN)
  • Table 22 Global Biomaterials Market Outlook, By Silk (2024-2032) ($MN)
  • Table 23 Global Biomaterials Market Outlook, By Hyaluronic Acid (2024-2032) ($MN)
  • Table 24 Global Biomaterials Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 25 Global Biomaterials Market Outlook, By Application (2024-2032) ($MN)
  • Table 26 Global Biomaterials Market Outlook, By Cardiovascular (2024-2032) ($MN)
  • Table 27 Global Biomaterials Market Outlook, By Stents & Grafts (2024-2032) ($MN)
  • Table 28 Global Biomaterials Market Outlook, By Heart Valves (2024-2032) ($MN)
  • Table 29 Global Biomaterials Market Outlook, By Pacemakers & Implantable Devices (2024-2032) ($MN)
  • Table 30 Global Biomaterials Market Outlook, By Orthopedic (2024-2032) ($MN)
  • Table 31 Global Biomaterials Market Outlook, By Joint Replacement (2024-2032) ($MN)
  • Table 32 Global Biomaterials Market Outlook, By Bone Plates & Screws (2024-2032) ($MN)
  • Table 33 Global Biomaterials Market Outlook, By Spinal Implants (2024-2032) ($MN)
  • Table 34 Global Biomaterials Market Outlook, By Ophthalmology (2024-2032) ($MN)
  • Table 35 Global Biomaterials Market Outlook, By Contact Lenses (2024-2032) ($MN)
  • Table 36 Global Biomaterials Market Outlook, By Intraocular Lenses (2024-2032) ($MN)
  • Table 37 Global Biomaterials Market Outlook, By Corneal Implants (2024-2032) ($MN)
  • Table 38 Global Biomaterials Market Outlook, By Dental (2024-2032) ($MN)
  • Table 39 Global Biomaterials Market Outlook, By Dental Implants (2024-2032) ($MN)
  • Table 40 Global Biomaterials Market Outlook, By Crowns & Bridges (2024-2032) ($MN)
  • Table 41 Global Biomaterials Market Outlook, By Dentures (2024-2032) ($MN)
  • Table 42 Global Biomaterials Market Outlook, By Wound Healing (2024-2032) ($MN)
  • Table 43 Global Biomaterials Market Outlook, By Surgical Sutures (2024-2032) ($MN)
  • Table 44 Global Biomaterials Market Outlook, By Tissue Sealants & Adhesives (2024-2032) ($MN)
  • Table 45 Global Biomaterials Market Outlook, By Dressings (2024-2032) ($MN)
  • Table 46 Global Biomaterials Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 47 Global Biomaterials Market Outlook, By Neural Implants (2024-2032) ($MN)
  • Table 48 Global Biomaterials Market Outlook, By Shunts (2024-2032) ($MN)
  • Table 49 Global Biomaterials Market Outlook, By Electrodes (2024-2032) ($MN)
  • Table 50 Global Biomaterials Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.